EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy

Affiliations

• ¹ Department of Pathology, Gyeonsang National University Hospital, Jinju, Korea.
• ² Division of Hematology-Oncology, Department of Internal Medicine, Gyeonsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea.
• ³ Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeonsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea.
• ⁴ Department of Cardiothoracic Surgery, Gyeonsang National University Hospital, Jinju, Korea.
• ⁵ Department of Pathology, Gyeonsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea.